May 18 | News
NEW YORK (AP) — Osiris Therapeutics Inc. said Thursday that Canadian regulators approved its stem cell therapy Prochymal, which is intended to treat a deadly side effect of bone marrow transplants.
|
May 16 | News
WASHINGTON (AP) — American consumers may soon be able to test themselves for the virus that causes AIDS in the privacy of their own homes, after a panel of experts on Tuesday recommended approval of the first rapid, over-the-counter HIV test.
|
May 15 | News
NEW HAVEN, Conn. (AP) — Achillion Pharmaceuticals Inc. said Tuesday it will receive incentives from regulators as it studies a new experimental treatment for the hepatitis C virus.
|
May 1 | News
The Food and Drug Administration on Tuesday approved a new treatment for Gaucher disease, a rare genetic disorder that can cause liver and neurological problems.The new drug is called Elelyso. It was developed by Protalix BioTherapeutics Inc. and licensed to Pfizer Inc., which is the largest...
|
Apr 30 | News
The Food and Drug Administration on Friday approved a new impotence drug, Vivus Inc.'s Stendra.
|
Apr 28 | News
U.S. regulators have approved use of a powerful Johnson & Johnson antibiotic to treat plague, an extremely rare, sometimes-deadly bacterial infection.
|
Apr 27 | News
Novartis Pharmaceuticals Corporation announced today that the FDA approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.
|
Apr 27 | News
GlaxoSmithKline plc announced today that the FDA has approved Votrient (pazopanib) for the treatment of patients with advanced soft tissue sarcoma who have received prior chemotherapy.
|
Apr 25 | News
REDWOOD CITY, Calif. (AP) — Industrial enzyme developer Codexis Inc. said Tuesday that the Food and Drug Administration has approved the company's process for manufacturing the active pharmaceutical ingredient in Merck's diabetes drug Januvia.
|
Apr 23 | News
LEXINGTON, Mass. (AP) — Amag Pharmaceuticals Inc. said Friday a European Union regulatory committee is recommending approval for its iron deficiency drug Feraheme.
|